Indefinite Delivery Contract 36E79720D0012
- Not listed
- Specgx LLC, doing business as Mallinckrodt Pharmaceuticals, was awarded a single-award Indefinite Delivery Contract valued at $28.22 million by the Department of Veterans Affairs National Acquisition Center on June 7, 2021. The contract provides buprenorphine hydrochloride/naloxone hydrochloride sublingual tablets to the VA, Department of Defense, Bureau of Prisons, and Indian Health Service through established pharmaceutical prime vendor programs. The initial period of performance runs from...
- The Department of Veterans Affairs National Acquisition Center awarded a single-award indefinite delivery contract to Radha Pharmaceuticals Inc. (UEI: C1S5SQ88KY67) for the supply of Bupropion Hydrochloride 12-hour Sustained Action Tablets on May 16, 2026. The contract carries a ceiling value of $8.28 million and utilizes firm-fixed pricing with a base year ordering period from May 16, 2026 through May 15, 2027, followed by four one-year option periods extending through May 15, 2031. This...
- Indivior Inc., a pharmaceutical manufacturer specializing in opioid use disorder and overdose prevention treatments, holds a multiple-award Federal Supply Schedule contract (FSS-61-IB) with the Department of Veterans Affairs for the procurement of drugs, pharmaceuticals, and hematology-related products. The indefinite delivery/indefinite quantity contract, awarded July 1, 2020, carries a ceiling value of $131.9 million and extends through June 30, 2026. As a civilian agency contract with no...
- The Department of Veterans Affairs National Acquisition Center awarded a single-award Indefinite Delivery Contract to Golden State Medical Supply, Inc. to procure bupropion hydrochloride immediate release tablets. The contract has a one-year base period of performance beginning on November 14, 2019, plus four one-year option periods, for a potential total value of $4.285 million. Task orders will be placed against the contract through November 13, 2024 to facilitate delivery of the...
- This federal contract IDV award is for the supply of Clonidine patches to the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The contract was awarded by the VA National Acquisition Center on November 30, 2020 to DR Reddy's Laboratories, Inc., a multinational pharmaceutical manufacturer and supplier. The contract is a single-award Indefinite Delivery Contract (IDC) with a total ceiling value of $11,604,529.80 over a base...
- Solco Healthcare US LLC was awarded a single-award Indefinite Delivery Contract on February 1, 2026, by the VA National Acquisition Center, a civilian federal agency, to supply Aripiprazole Tablets across multiple dosage strengths (2mg, 5mg, 10mg, 15mg, 20mg, and 30mg). The contract carries a ceiling value of $5,954,889.35 and encompasses a base year ordering period from February 1, 2026, to January 31, 2027, with four optional one-year renewal periods extending through January 31, 2027. This...
- This indefinite delivery contract (IDC) was awarded by the National Acquisition Center, a civilian agency of the U.S. government, to Radha Pharmaceuticals Inc., a minority-owned small disadvantaged business. The contract, valued at up to $15,026,406.75, provides for the delivery of Bupropion SA 12HR tablets in various bottle sizes and quantities to the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and Indian Health Service over a base year period from May 16, 2021...
- Emergent Devices, Inc., a pharmaceutical manufacturer specializing in naloxone products, holds a multiple-award Federal Supply Schedule contract under the Pharmaceuticals and Drugs (FSS-61-IB) schedule with the Department of Veterans Affairs' Veterans Integrated Service Network 12. The indefinite delivery vehicle was awarded on August 15, 2023, with an $11.8 million ceiling value and a performance period extending through August 14, 2028. This contract does not utilize a set-aside and...
- The federal contract IDV award is for the supply of EMTRICITABINE 200MG/TENOFOVIR DISOPROXIL FUMARATE 300MG Tablets to the Department of Veterans Affairs (VA), Bureau of Prisons (BOP), and Indian Health Service (IHS). The single-award contract was issued by the VA National Acquisition Center to the prime contractor Golden State Medical Supply, Inc., a for-profit manufacturer and distributor of pharmaceuticals. The $3,599,069.90 ceiling value contract has a one-year base period with four one-year...
- The federal contract IDV award is for the procurement of Naproxen NA tablets by the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The contract was awarded to DR Reddy's Laboratories, Inc., a multinational pharmaceutical company, on February 4, 2023 for a base period of one year with four one-year option periods, resulting in a total potential period of performance of up to five years. The contract has a ceiling value...
The Department of Veterans Affairs awarded a single-award indefinite delivery contract to DR Reddy's Laboratories, Inc. to supply an estimated 140,000 boxes annually of various strengths of Buprenorphine/Naloxone Film Sublingual. The contract has a one-year base period of performance beginning February 4, 2020 with four one-year option periods and a potential value of $42,763,747.32. The original solicitation sought to establish a prime vendor contract to supply Buprenorphine/Naloxone Film Sublingual to the VA, DoD, BOP and IHS through their respective Pharmaceutical Prime Vendor programs. Offerors were required to provide pricing for the base year and all option periods, identify the exact drug name to appear on labels, and have a unique NDC number. The solicitation did not include any set-aside provisions and specified place of performance within the United States. Estimated annual requirements included over 6,500 boxes of the 12mg/3mg strength, 20,000 boxes of the 2mg/0.5mg strength, 6,700 boxes of the 4mg/1mg strength, and over 107,000 boxes of the 8mg/2mg strength. The contract aims to establish an uninterrupted supply of Buprenorphine/Naloxone Film Sublingual, which is used to treat opioid addiction, for the VA and other federal agencies through their prime vendor networks. The single-award structure and option periods indicate the goal of procuring these pharmaceuticals in a cost-effective manner over multiple years from a single qualified source.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Terminate for Convenience | $0 | 2/4/20 | |
| Not listed | Not listed | $0 | 1/23/20 |
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Buprenorphine/Naloxone Film, Sublingual | 36E79719R0034 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 | Solicitation 1/1 | 10/18/19, 4:46 PM |